48,833
edits
Difference between revisions of "Lymphangioleiomyomatosis"
Jump to navigation
Jump to search
Lymphangioleiomyomatosis (view source)
Revision as of 22:13, 24 October 2015
, 22:13, 24 October 2015no edit summary
(+hypothesis) |
|||
| Line 18: | Line 18: | ||
| Assdx = | | Assdx = | ||
| Syndromes = [[tuberous sclerosis]] | | Syndromes = [[tuberous sclerosis]] | ||
| Clinicalhx = almost always women of childbearing age, recurrent pneumothorax | | Clinicalhx = almost always women of childbearing age, recurrent [[pneumothorax]] | ||
| Signs = | | Signs = | ||
| Symptoms = dyspnea | | Symptoms = dyspnea | ||
| Line 35: | Line 35: | ||
==General== | ==General== | ||
*Clinical: [[dyspnea]], recurrent pneumothorax. | *Clinical: [[dyspnea]], recurrent [[pneumothorax]]. | ||
*May be an indication for lung transplantation. | *May be an indication for lung transplantation. | ||
*Non-neoplastic muscle proliferation versus tumour that can metastasize.<ref name=pmid20235883>{{Cite journal | last1 = Taveira-DaSilva | first1 = AM. | last2 = Pacheco-Rodriguez | first2 = G. | last3 = Moss | first3 = J. | title = The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. | journal = Lymphat Res Biol | volume = 8 | issue = 1 | pages = 9-19 | month = Mar | year = 2010 | doi = 10.1089/lrb.2009.0024 | PMID = 20235883 }}</ref> | *Non-neoplastic muscle proliferation versus tumour that can metastasize.<ref name=pmid20235883>{{Cite journal | last1 = Taveira-DaSilva | first1 = AM. | last2 = Pacheco-Rodriguez | first2 = G. | last3 = Moss | first3 = J. | title = The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. | journal = Lymphat Res Biol | volume = 8 | issue = 1 | pages = 9-19 | month = Mar | year = 2010 | doi = 10.1089/lrb.2009.0024 | PMID = 20235883 }}</ref> | ||